biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Rob Hutchison Obituary

<< Previous

Bullboard Posts

Next >>

Post by InitiumMMXXIIIon Feb 27, 2024 11:58am

268 Views

Post# 35901580

Rob Hutchison Obituary

Rob Hutchison passed away on November 24, 2023. I heard about it a couple of days before Christmas, but because I couldn't find a supporting document at that time, I didn't want to post the news. I did a search yesterday and found Rob's obituary in the Vancouver Sun/The Province obits section. It was posted there on December 1, 2023. My earlier search either didn't turn it up or I missed it.

In any event, it's sad news. He and Bioasis played a big part in my life. and many of yours, for many years.

My condolences to his family and friends.

jd

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”